PL2124922T3 - Kompozycja zawierająca rutynę i wielonienasycony kwas tłuszczowy mający aktywność inhibitującą względem 5 αlfa-reduktazy - Google Patents

Kompozycja zawierająca rutynę i wielonienasycony kwas tłuszczowy mający aktywność inhibitującą względem 5 αlfa-reduktazy

Info

Publication number
PL2124922T3
PL2124922T3 PL08719394T PL08719394T PL2124922T3 PL 2124922 T3 PL2124922 T3 PL 2124922T3 PL 08719394 T PL08719394 T PL 08719394T PL 08719394 T PL08719394 T PL 08719394T PL 2124922 T3 PL2124922 T3 PL 2124922T3
Authority
PL
Poland
Prior art keywords
rutin
reductase
alpha
composition
fatty acid
Prior art date
Application number
PL08719394T
Other languages
English (en)
Inventor
Giammaria Giuliani
Anna Benedusi
Sergio Baroni
Original Assignee
Giuliani Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani Spa filed Critical Giuliani Spa
Publication of PL2124922T3 publication Critical patent/PL2124922T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PL08719394T 2007-03-21 2008-03-18 Kompozycja zawierająca rutynę i wielonienasycony kwas tłuszczowy mający aktywność inhibitującą względem 5 αlfa-reduktazy PL2124922T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000555A ITMI20070555A1 (it) 2007-03-21 2007-03-21 Composizione provvista di attivita' di inibizione sulla 5 alfa-reduttasi
PCT/IB2008/000772 WO2008114141A2 (en) 2007-03-21 2008-03-18 Composition comprising rutin and polyunsaturated fatty acid having an inhibitory activity on 5 alpha-reductase
EP20080719394 EP2124922B1 (en) 2007-03-21 2008-03-18 Composition comprising rutin and polyunsaturated fatty acid having an inhibitory activity on 5 alpha-reductase

Publications (1)

Publication Number Publication Date
PL2124922T3 true PL2124922T3 (pl) 2013-10-31

Family

ID=39766557

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08719394T PL2124922T3 (pl) 2007-03-21 2008-03-18 Kompozycja zawierająca rutynę i wielonienasycony kwas tłuszczowy mający aktywność inhibitującą względem 5 αlfa-reduktazy

Country Status (9)

Country Link
US (1) US9144560B2 (pl)
EP (1) EP2124922B1 (pl)
EA (1) EA015819B1 (pl)
ES (1) ES2424323T3 (pl)
IT (1) ITMI20070555A1 (pl)
PL (1) PL2124922T3 (pl)
PT (1) PT2124922E (pl)
UA (1) UA98638C2 (pl)
WO (1) WO2008114141A2 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2352493E (pt) * 2008-11-03 2014-03-20 Giuliani Spa Utilização terapêutica, dietética ou cosmética de compostos com atividade anti-apoptótica específica para a caspase-3 e composições contendo esses compostos
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
IT1395122B1 (it) * 2009-07-29 2012-09-05 Giuliani Spa Composizione per uso farmaceutico o cosmetico o dietetico atta a svolgere un effetto di pigmentazione dei capelli
ITMI20091940A1 (it) 2009-11-05 2011-05-06 Functional Point S R L Composizione comprendente resveratrolo e almeno un polifenolo del vino rosso e suoi usi.
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
DE102011086635A1 (de) * 2011-11-18 2013-05-23 Henkel Ag & Co. Kgaa Haarpflegemittel mit Antischuppenmitteln und kationischen Silikonen
DE102011086636A1 (de) * 2011-11-18 2013-05-23 Henkel Ag & Co. Kgaa Haarpflegemittel mit Aminosäuren und kationischen Silikonen
US20130267598A1 (en) * 2012-02-23 2013-10-10 Dignity Sciences Limited Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of reducing sebum production using same
AU2013406790B2 (en) 2013-12-03 2017-09-28 Colgate-Palmolive Company Oral care compositions
SG10201912145VA (en) 2014-06-04 2020-02-27 Dignity Sciences Ltd Pharmaceutical compositions comprising dgla and use of same
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093516B1 (en) * 1982-04-29 1986-10-01 Efamol Limited Pharmaceutical composition
US6150405A (en) * 1985-07-18 2000-11-21 Proctor; Peter H. Hair loss treatment with ascorbates
GB9419715D0 (en) 1994-09-30 1994-11-16 Boots Co Plc Hair stimulant composition
AU7678796A (en) * 1995-11-13 1997-06-05 Arcturus Pharmaceutical Corporation Method for the treatment, prevention or minimization of hair loss using a source of fatty acids
US6576660B1 (en) * 1997-10-31 2003-06-10 Arch Development Corporation Methods and compositions for regulation of 5-α-reductase activity
US20030224071A1 (en) * 1999-08-20 2003-12-04 Howard Murad Pharmaceutical compositions and methods for managing connective tissue ailments
FR2829692B1 (fr) 2001-09-17 2004-10-15 Lehning Lab Composition selective de six categories de substances preservant l'equilibre physiologique chez l'homme comprenant un complexe de micronutriments,un complexe d'antioxydants et un complexe d'acides gras.
WO2004078189A1 (de) * 2003-03-03 2004-09-16 Bioplanta Arzneimittel Gmbh Verwendung von rutin und isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen sowei bei anderen affektiven störungen
KR100499564B1 (ko) 2003-03-28 2005-07-07 신석봉 모발의 재생방법 및 발모제 조성물
US7452527B2 (en) * 2003-03-28 2008-11-18 Murad, Inc. Methods of promoting hair growth
FR2865635B1 (fr) 2004-01-29 2007-10-12 Oreal Procede de preparation d'une composition de traitement cosmetique a partir de fluide sous pression, et d'actifs cosmetiques non colorants sensibles a un stimulus exterieur
GB0411166D0 (en) 2004-05-19 2004-06-23 Bionovate Ltd Treatment for asthma and arthritis

Also Published As

Publication number Publication date
US9144560B2 (en) 2015-09-29
WO2008114141A2 (en) 2008-09-25
PT2124922E (pt) 2013-08-26
US20100034904A1 (en) 2010-02-11
UA98638C2 (ru) 2012-06-11
ITMI20070555A1 (it) 2007-06-20
WO2008114141A3 (en) 2008-12-04
EP2124922B1 (en) 2013-05-15
EA015819B1 (ru) 2011-12-30
ES2424323T3 (es) 2013-10-01
EA200901221A1 (ru) 2010-04-30
EP2124922A2 (en) 2009-12-02

Similar Documents

Publication Publication Date Title
PL2124922T3 (pl) Kompozycja zawierająca rutynę i wielonienasycony kwas tłuszczowy mający aktywność inhibitującą względem 5 αlfa-reduktazy
EP2136844A4 (en) COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF
IL213747A (en) Hydrolase suppressants for fatty acids, preparations containing them and their uses
EP2046108A4 (en) CHANGE OF FATTY ACID COMPOSITION OF RICE
EP2121576A4 (en) MULTIPLE UNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES AND APPLICATIONS THEREOF
EP2172453A4 (en) COMPOUND HAVING 11 ß-HSD1 INHIBITION ACTIVITY
EP2015781A4 (en) COMPOSITIONS HAVING ANTIANGIOGENIC ACTIVITY AND USES THEREOF
EP2046957A4 (en) DATURURASES OF FATTY ACIDS AND USES THEREOF
IL210233A0 (en) Omega 3 fatty acid formulations
EP2037872A4 (en) COMPOSITIONS COMPRISING BITULONIC ACID
LT3090748T (lt) Kompozicijos, apimančios nukleotido ir oligonukleotido provaistus
EP1945179A4 (en) HYALURONIDASE INHIBITORS WITH POLY-GAMMA GLUTAMIC ACID AS AN ACTIVE COMPONENT
GB2444896B (en) Compositions comprising polyunsaturated fatty acids
EP2051964A4 (en) FATTY ACID HYDROLASE AMIDE INHIBITORS
IL187812A0 (en) Imidazo-and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type 1
EP1958612A4 (en) TREHALOSE FATTY ACID ESTER COMPOSITION
IL190728A0 (en) Intravenous essential fatty acid emulsion
HK1115373A1 (en) Intermolecular compound of fatty acid triglyceride
EP2079836A4 (en) HEAT STABLE ENZYMATIC COMPOSITIONS
HK1130696A1 (en) Skin external preparation containing triterpenic acid
IL199056A0 (en) Acetaminophen compositions having minimized side effects including reduced hepato-toxicity
EP2007523A4 (en) FATTY ACID SECONDARY PRODUCTS AND METHODS OF USE
EP1996334A4 (en) Fatty acid by-products and methods of use therefor
IL227318A (en) Preparations containing enzyme for lowering immunological pressure
EP2094242A4 (en) IN A MATRIX EMBEDDED COMPOSITIONS WITH ORGANIC ACIDS AND FATTY ACIDS